IFI30, MYO7A, HPS4, and NEU4 have not been mentioned in studies on the background of gastric cancer, and we speculate that these four genes possess sufficient potential to influence the progression of gastric cancer, and further exploration could potentially facilitate the betterment of the current situation in gastric cancer research and clinical application. This evidence concerns the gene HPS4 and gastric cancer.